L-Thyroxine L-甲状腺素

CAS 51-48-9 MFCD00002595

化学结构图

51-48-9
SMILES: N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O

化学属性

Mol. FormulaC15H11I4NO4
Mol. Weight777
Melting Point223
Solubility不溶
Density2.635

别名和识别编码

Chemical NameL-Thyroxine
Synonym 3,3',5,5'-Tetraiodo-L-thyronine L-Thyroxine O-(4-羟基-3,5-二碘苯基)-3,5-二碘-L-酪氨酸;甲四碘胺;左旋甲状腺素 3,3',5,5'-Tetraiodo-L-thyronine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; L-2-Amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid Thyroxin L-甲状腺素 THX Thyreoideum 3,3′,5,5″-四碘代-L-甲状腺原氨酸 3-[4-(4-羟基-3,5-二碘苯氧基)-3,5-二碘苯基]-L-丙氨酸 T4 Thyroxinal L-3,5,3',5'-Tetraiodothyronine Tetraiodothyronine Thyroxine, L- L-Thyroxin L-T4 O-(4-羟基-3,5-二碘苯基)-3,5-二碘-L-酪氨酸 Levothyroxine (-)-Thyroxine T4 (Hormone)
Beilstein Registry Number2228515
PubChem Substance ID5819
CAS Number51-48-9
EC Number200-101-1
MDL NumberMFCD00002595
Chemical Name TranslationL-甲状腺素
Alfabeta NameHYDROXYDIIODOPHENYLDIIODOTYROSINE OL43535()--------,,
Wiswesser Line NotationQVYZ1R CI EI DOR DQ CI EI
LabNetwork Molecule IDLN00165250
InChIInChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {SNA} Hormones, 细胞培养, 试剂和添加剂
  • {SNA} Bioactive Small Molecules, Cell Culture, Hormones, Reagents and Supplements,
  • {SNA} Analytical Standards,
  • {SNA} Catecholamine, Cofactor, Cytokines, Growth Factors and Hormones, Hormones, Metabolic Pathways, Metabolites and Cofactors on the Metabolic Pathways Chart, Other Protein/Peptide Hormones, Peptides and Proteins, Peptides for Cell Biology, Thyroid Hormones, Thyroxine, Thyroxine (T4), 代谢组学, 细胞信号转导和神经科学, 细胞生物学
  • {SNA} Analytical Standards, Chromatography, Pharmaceutical Standards, Pharmacopeia Standards, USP Standards,
  • {SNA} Analytical Standards

产品应用

  • L- 甲状腺素 (T4) 和三吲哚-L-甲状腺原氨酸(triiodo-L-thyronine,T3) 是含吲哚激素,是由甲状腺滤泡细胞里的甲状腺球蛋白产生的。L-甲状腺素通过影响DNA转录和蛋白质合成来刺激代谢和调控生长和发育。

相关文献及参考

  • [2]. Corriveau S, et al. Levothyroxine treatment generates an abnormal uterine contractility patterns in an in vitro animalmodel. J Clin Transl Endocrinol. 2015 Sep 9;2(4):144-149.
  • DeGroot, L.J., and Niepomniszcze, H., Biosynthesis of thyroid hormone: basic and clinical aspects. Metabolism 26 , 665-718, (1977)
  • Merck: 14,9415 Beilstein: 14,IV,2373
  • Oppenheimer, J.H., et al., Advances in our understanding of thyroid hormone action at the cellular level. Endocr. Rev. 8 , 288-308, (1987) 摘要
  • Tiefenbach, J., et al., A Live Zebrafish-based Screening System For Human Nuclear Receptor Ligand And Cofactor Discovery. PLoS ONE 5 , e9797, (2010) 摘要
  • [1]. Arici M, et al. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J. 2018 M
  • [1]. Arici M, et al. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J. 2018 Mar 28;65(3):317-323.

安全信息

WGK Germany3
RTECSYP2833500
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
Safety Statements
  • S22 Do not breathe dust 不要吸入粉尘;
  • S24/25 Avoid contact with skin and eyes 避免皮肤和眼睛接触;
GHS Symbol
Precautionary statements
  • P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛,皮肤或衣服。
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - man
DOSE/DURATION           : 63 ug/kg
TOXIC EFFECTS :
   Behavioral - hallucinations, distorted perceptions
   Cardiac - pulse rate increase, without fall in BP
REFERENCE :
   JTCTDW Journal of Toxicology, Clinical Toxicology.  (Marcel Dekker, 270
   Madison Ave., New York, NY 10016)  V.19-    1982-  Volume(issue)/page/year:
   20,517,1983

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - woman
DOSE/DURATION           : 400 ug/kg/2D-I
TOXIC EFFECTS :
   Behavioral - coma
   Cardiac - arrhythmias (including changes in conduction)
REFERENCE :
   ICMED9 Intensive Care Medicine.  (Springer-Verlag New York, Inc., Service
   Center, 44 Hartz Way, Secaucus, NJ 07094)  V.3-    1977-
   Volume(issue)/page/year: 13,33,1987

TYPE OF TEST            : Unscheduled DNA synthesis
ROUTE OF EXPOSURE       : Subcutaneous
TEST SYSTEM             : Rodent - rat
DOSE/DURATION           : 6250 ug/kg/2D (Continuous)
REFERENCE :
   BEXBAN Bulletin of Experimental Biology and Medicine (English Translation).
   Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY
   10013)  V.41-    1956-  Volume(issue)/page/year: 72,942,1971

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 450 ug/kg
SEX/DURATION            : female 7-15 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 1400 ug/kg
SEX/DURATION            : female 16-22 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - biochemical and metabolic
REFERENCE :
   ACEDAB Acta Endocrinologica, Supplementum (Copenhagen).  (Periodica,
   Skolegade 12 E, DK-2500 Valby, Denmark)  No.1-    1948-
   Volume(issue)/page/year: 215,73,1978

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 410 mg/kg
SEX/DURATION            : female 3 week(s) pre-mating
                          female 1-20 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - cytological changes (including
   somatic cell genetic material)
REFERENCE :
   CTSRCS Cell and Tissue Research.  (Springer-Verlag New York, Inc., Service
   Center, 44 Hartz Way, Secaucus, NJ 07094)  V.148-    1974-
   Volume(issue)/page/year: 260,403,1990

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 12 mg/kg
SEX/DURATION            : female 9-11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
   KAIZAN Kaibogaku Zasshi.  Journ

其他信息

  • 不溶于水、醇和大多数有机溶剂,在矿物油存在下溶于醇。

系列性分类


相关产品推荐